Biocartesian
YC S24San Francisco, US · Founded 2023 · 2 employees · 1 known investors
Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.
Also known as coordna bio
AI & Machine LearningBiotechDeep TechHealthtechHard TechB2BDiagnosticsDrug discoveryUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (S24)
Biocartesian was founded in 2023 by Ian Dardani and Jess Li.
ID
Ian DardaniinCo-founder & CEOHe previously worked at Cambridge's Bioscience Enterprise and holds a PhD in Bioengineering from the University of Pennsylvania.
Investors · 1
In the news
Frequently asked questions
- What does Biocartesian do?
- Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.
- Who founded Biocartesian?
- Biocartesian was founded by Ian Dardani, Jess Li in 2023.
- Who are Biocartesian's investors?
- Biocartesian's investors include Y Combinator.
- Where is Biocartesian headquartered?
- Biocartesian is headquartered in San Francisco, US.